A Study of MEMP1972A in the Prevention of Allergen-Induced Airway Obstruction in Patients With Mild Asthma (SOLARIO)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey Harris, MD, Ph.D
Genentech, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Calgary, Alberta, Canada
- Facility name not stated
Edmonton, Alberta, Canada
- Facility name not stated
Vancouver, British Columbia, Canada
- Facility name not stated
Hamilton, Ontario, Canada
- Facility name not stated
Ste. Foy, Quebec, Canada
- Facility name not stated
Saskatoon, Saskatchewan, Canada
- Facility name not stated
Stockholm, Sweden
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2010
- Primary completion
- 31 Aug 2011
- Completion
- 31 Jan 2012
- Last update posted
- 2 Nov 2016
- Registered enrollment
- 29
- Registry id
- NCT01196039
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.